At first, IVC (inferior vena cava) filters seemed to be a great idea. Anticoagulant medications can be tricky, causing an elevated risk of serious hemorrhaging, and some patients cannot handle them at all. Placing a small metal cage into the primary artery leading to the heart and lungs in order to trap clots and prevent them from reaching it appeared to be the ideal solution. So, why is it that this particular cure has proven to be worse than the disease?
The next round of bellwether trials in the Pinnacle multidistrict litigation will move forward despite a petition by the defendants Johnson & Johnson and DePuy Orthopedics to prevent them. The 5th Circuit federal court denied their request and the trials are scheduled to begin late next month. Earlier this year, another round of trials related to the case resulted in a record $502-million dollar verdict against Johnson & Johnson.
Recent efforts to reach a settlement agreement in the Cook IVC Filter Litigation were unsuccessful, meaning a select number of cases for early “bellwether” trials could get underway next year, if additional settlement attempts don’t result in an agreement.
The days long deluge of rain along the U.S. Gulf Coast has soaked Southeastern states from Louisiana to Florida, bringing flash floods and additional risks for drivers maneuvering through the soaking rain. All motorists have to deal with driving in the rain from time to time and there are some do’s and don’ts that may surprise you.
In Florida, motorists caught in a downpour can turn on their headlights and set their windshield wipers on the fastest setting possible, but it’s illegal for them to drive with their hazard lights blazing.
The new interactive game app, Pokémon Go, has safety advocates concerned that the already serious problem of distracted driving is only going to get worse. Although no serious injuries have been reported due to drivers or motorists playing the game, the craze over the smartphone game app led to a series of accidents and traffic offenses in Japan soon after its release July 6, and is now being blamed for similar problems here in the United States.
Concerta, a pharmaceutical manufactured and marketed by Johnson & Johnson subsidiary Janssen Pharmaceutica, is one of the latest in a line of prescription drugs that have been found to have serious, and even fatal side effects that the company allegedly knew about and of which they failed to inform the public. In a society and at a time when people are looking for “quick fixes” for perceived disorders, such stories are becoming increasingly common.
Proton pump inhibitors (PPIs), such as Nexium and Prilosec, have been associated with a host of health dangers, including osteoporosis, inflammation of the stomach lining, gastrointestinal disorders, magnesium deficiency, and most seriously, severe kidney damage and heart attacks. Recent research has also linked these medications to dementia in older patients.
Considering our government is bought and paid for by Big Pharma, it’s only fitting that Janssen Pharmaceuticals has used the Beltway’s time-honored “Friday news dump” to inform the public that its blockbuster diabetes medication, Invokana, causes kidney injuries when it quietly updated Invokana’s warning label on Friday, May 20, 2016. Invokana is in a class of medications called sodium glucose cotransporter 2 (SGLT2) inhibitors which are intended to treat high blood sugar in type 2 diabetics.
Summer is in full swing and with children out of school that often means families are taking vacations, travelling, and spending more time driving on the road. This is a great time of year for making lasting memories with loved ones, but a traffic accident should not be one of them. Unfortunately, the months of July and August have the highest number of fatal car accidents, according to the National Highway Traffic Safety Administration.
At a time when some legislators in Washington are calling on federal regulators to do a better job of protecting private and retail investors, there is a new man heading up the brokerage industry regulator authority, FINRA. FINRA is an SRO, or self-regulatory organization which oversees the securities industry and whose mission is to protect investors.
If you have been in a car accident you may have some questions about Personal Injury Protection or PIP, an extension of car insurance available in some states that covers medical expenses and in some cases lost wages and other damages. It is often referred to as “no-fault” insurance which basically means that regardless of who is at fault in an auto accident your auto insurance pays first. Understanding how the system works can help you if you have been injured.
A recent report published in the British Medical Journal is a grim reminder of something many medical malpractice attorneys are tragically already aware - medical errors are killing thousands of people in the United States. In fact, analysis shows they could account for nearly 700 deaths a day.
Virginia Buchanan, an attorney with the Levin, Papantonio law firm, is not surprised by the findings. She has been handling medical malpractice cases for nearly 25 years.
News of the connection between proton pump inhibitors (PPIs) such as Prilosec and Nexium has been out for several months, having been reported on Ring of Fire and elsewhere. That's grim enough, but the latest news is even more alarming. It turns out that when it comes to PPIs, kidney disease is just the tip of the iceberg. These drugs do far more damage in more ways than previously thought.
Talcum powder, a seemingly innocuous, everyday household product for well over a century, has turned deadly for some users. Specifically, for the women who have found themselves victim of ovarian cancer as a result of using talcum powder in the genital region. What manufacturers have known (or should have known) for at least 45 years is that the substance can cause chronic inflammation – a condition that medical science has connected with the development of some types of cancer.
The 25-million dollar fine recently levied against financial services and insurance giant, MetLife, demonstrates the need investors have for greater federal protection. MetLife agreed to pay the fine, to settle allegations that the company sometimes overstated the cost of a customer’s variable annuity contract and that the company failed to tell customers a proposed replacement would impact features of their existing variable annuity. The result is that customers ended up paying more annually and had some features of their investment lost or downgraded.